-+ 0.00%
-+ 0.00%
-+ 0.00%

BIOVERSYS REPORTS RESULTS FROM PHASE 2A ENABLE STUDY FOR TUBERCULOSIS TREATMENTS CONTAINING ALPE

Reuters·11/20/2026 06:24:31

Please log in to view news